Intended Use Study of the BD SurePath Plus™ Pap

Inclusion Criteria: Study subjects must give voluntary written informed consent to participate in this study. \- Females ages 18 - 35 years, inclusive; or women at high- risk for cervical cancer or its precursor lesions. High-risk is defined as: * Have had a previous high-risk HPV positive test in the last 5 years; or * Have had an abnormal Pap test (ASC-US or higher) in the last 5 years; or * Have not been screened for cervical cancer by either a Pap test or HPV test in the last 5 years. Exclusion Criteria: * Subjects who are 36 years of age or greater who are not high risk, and/or: 1. Have not had an abnormal Pap in the last 5 years; or 2. Have not had a positive HPV test in the last 5 years; or 3. Have been screened in the last 5 years without an abnormal Pap or HPV result * Subjects known to be pregnant or planning to become pregnant prior to the potential six months follow-up visit (self-reported). Subjects who decide to become pregnant prior to the six-month follow up visit or found to be pregnant after the first visit, but prior to the six-month follow-up visit will be terminated from further study participation at that time * Subjects who have had a prior complete or partial hysterectomy involving removal of the cervix. * Subjects who have had an application of chemical compounds to the cervical area within the 24 hours prior to study entry, e.g., acetic acid, iodine, spermicide, douche, anti-fungal medications, etc. * Subjects on whom conization, LEEP, laser surgery, or cryosurgery has been performed within the past five months. * Subjects currently undergoing radiation and/or chemotherapy. * Subjects under the age of 18. * Subjects who have previously received a HPV vaccine with any number of doses.